Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Hanmi Pharm (128940 KS)
Watchlist
142
Analysis
Health Care
•
South Korea
Hanmi Pharm. Company Ltd. produces pharmaceutical products, including antibiotics, vitamins, and intestinal tonics. The Company also provides beverages and processes soft capsules for other pharmaceutical firms.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Yuhan Corp
•
21 Dec 2016 15:45
20 Million Chickens (And Ducks) Culled in Korea
It is estimated that more than 20 million chickens (and ducks) have been culled in Korea in the past several weeks, representing about 12% of all...
Douglas Kim
Follow
731 Views
Share
bullish
•
SillaJen Inc
•
21 Nov 2016 13:33
SillaJen IPO Part 3 - Competitive Strengths of Product (Pexa-Vec)
*Â In Part 3 (as below), I summarized the competitive strengths of product (Pexa-Vec).SillaJen's Pexa-Vec is an advanced liver cancer treatment...
Sanghyun Park
Follow
390 Views
Share
bullish
•
SillaJen Inc
•
03 Nov 2016 11:26
SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...
Sanghyun Park
Follow
406 Views
Share
bullish
•
SillaJen Inc
•
02 Nov 2016 15:20
SillaJen IPO Part 1 - Schedule, Financials & Valuation
SillaJen Biotherapeutics (established in 2006) submitted the IPO report. The company develops potent multi-functional immunotherapeutics for...
Sanghyun Park
Follow
525 Views
Share
bullish
•
Hanmi Pharm
•
27 Oct 2016 13:48
Hanmi Pharmaceutical: This Korean Pharma Giant's Stock Could Rebound More than 50%.
Hanmi Pharm Co Ltd (128940 KS)Â stock has fallen from recent highs after Boehringer pulled out of an oncology deal and short-sellers piled on the...
Dr. Bhavneesh Sharma, MD, MBA
806 Views
Share
First
Previous
24
25
26
27
28
29
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x